Clinical Trial Update: Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update reports safety and efficacy results for SNS-595 in patients with advanced small cell lung cancer. The results summarize the safety profile …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• SNS-595

Snippet

Sponsor: Sunesis Pharmaceuticals | Conditions: Carcinoma, Small Cell, Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-07-26